Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society

被引:3
|
作者
Soylar, Oznur Kilic [1 ]
Kilinc, Oguz [1 ]
Ellidokuz, Hulya [2 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkey
[2] Dokuz Eylul Univ, Biostat Discipline, Dept Prevent Oncol, Izmir, Turkey
关键词
Community-acquired pneumonia; pneumonia treatment guideline; adherence with guideline;
D O I
10.5152/ttd.2015.4437
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy. MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline. RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients. CONCLUSION: Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [31] Elderly Patients with Community-Acquired Pneumonia Optimal Treatment Strategies
    Thiem, Ulrich
    Heppner, Hans-Juergen
    Pientka, Ludger
    DRUGS & AGING, 2011, 28 (07) : 519 - 537
  • [32] Treatment of Elderly Patients With Community-Acquired Pneumonia With the Guidance of Procalcitonin
    Roh, Yong Ho
    Lee, Byoung Jun
    CHEST, 2013, 144 (04)
  • [33] Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia
    Bassetti, Matteo
    Melchio, Monica
    Giacobbe, Daniele Roberto
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (05) : 649 - 656
  • [35] Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization
    Falagas, Matthew E.
    Metaxas, Eugenios I.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (08) : 913 - 923
  • [36] Did an Acute Medical Assessment Unit improve the initial assessment and treatment of community-acquired pneumonia-a retrospective audit
    Tripp, David G.
    NEW ZEALAND MEDICAL JOURNAL, 2012, 125 (1354) : 60 - 67
  • [37] British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009
    Lim, W. S.
    Baudouin, S. V.
    George, R. C.
    Hill, A. T.
    Jamieson, C.
    Le Jeune, I.
    Macfarlane, J. T.
    Read, R. C.
    Roberts, H. J.
    Levy, M. L.
    Wani, M.
    Woodhead, M. A.
    THORAX, 2009, 64 : 1 - 55
  • [38] Pneumonia in palliative care patients, part 1 - principles of diagnosis and treatment, hospital-acquired pneumonia, and community-acquired pneumonia
    Nowak, Piotr J.
    Zasowska-Nowak, Anna
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2018, 10 (04): : 159 - 175
  • [39] A Comparison of Pneumonia Severity Assessment Scores in Predicting Outcomes of Hospitalized Patients with Community-Acquired Pneumonia
    Arumairaj, A. J.
    Habtes, I.
    Park, H.
    Gapuz, K.
    Kaliamurthy, M.
    Oliva, O.
    Newman, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [40] Update in adult community-acquired pneumonia: key points from the new American Thoracic Society/Infectious Diseases Society of America 2019 guideline
    Metlay, Joshua P.
    Waterer, Grant W.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 203 - 207